Urine-derived stem cells for potential use in bladder repair

Area of Science:

• Regenerative Medicine
• Urology
• Stem Cell Biology

Background:

• Engineered bladder tissues for cystoplasty face contamination risks from patient biopsy-derived cells.
• Autologous mesenchymal stem cells (MSCs) are a potential source but have limitations.
• Existing adult stem cell sources require further investigation for bladder repair.

Purpose of the Study:

• To identify and evaluate a novel, safe, and efficient cell source for bladder tissue engineering.
• To explore the potential of urine-derived stem cells (USCs) for bladder regeneration.
• To overcome the limitations of current cell sources in bladder reconstruction.

Main Methods:

• Identification and characterization of stem cells isolated from urine.
• Assessment of urine-derived stem cells' (USCs) expansion, self-renewal, and paracrine properties.
• Induction of USCs differentiation into bladder smooth muscle and urothelial cells.

Main Results:

• Urine-derived stem cells (USCs) exhibit high expandability, self-renewal capacity, and paracrine properties.
• USCs can be obtained noninvasively, simply, and at low cost.
• USCs demonstrate efficient differentiation into bladder cell lineages.

Conclusions:

• Urine-derived stem cells (USCs) represent a promising and advantageous cell source for bladder tissue engineering and regenerative medicine.
• The noninvasive nature and high differentiation efficiency of USCs address key challenges in current bladder reconstruction.
• USCs offer a viable alternative to autologous MSCs and biopsy-derived cells for creating safe and effective engineered bladder tissues.